Genetic variations in the metformin target (ETFDH, inhibitor), the ubiquinone target (SDHA, cofactor) and the vitamin C target (EGLN1, cofactor) are associated with the risk of ADHD across multiple brain regions. This evidence concerns the gene EGLN1 and attention deficit-hyperactivity disorder.